Enzo Biochem (ENZ) Reports Q1 Loss of $0.13

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Enzo Biochem (ENZ) Reports Q1 Loss of $0.13

Enzo Biochem Reports Fiscal First Quarter Results

December 10, 2019 4:15 PM EST

Company Announces Plan to Unlock Value for Therapeutics Subsidiary

Announces Three Lab-to-Lab Relationships

Announces Appointment of New Chief Financial Officer

Enzo Continues to Take Steps in Creating New Model for Modern Day Diagnostics Company

NEW YORK--(BUSINESS WIRE)-- Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and life sciences company focusing on delivering and applying advanced technology capabilities to produce affordable, reliable products and services that enable its customers to meet their clinical needs, today reported... More